Loading...
In patients with obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP) can induce favorable changes in components of the metabolic syndrome. To quantitate these potential benefits, researchers in India conducted a double-blind, crossover trial: 86 patients with moderate-to-severe OSA received 3 months of CPAP and 3 months of sham CPAP, assigned in random order. Most participants were overweight middle-aged men. At baseline, 87% of participants met criteria for metabolic syndrome, but none were taking antihypertensive, lipid-lowering, or antidiabetic drugs.
Reversal of metabolic syndrome occurred in 11 patients during the CPAP phase, but in only 1 patient during the sham phase. Improvements in blood pressure, fasting gluco…